Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid

Similar documents
PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

PACKAGE LEAFLET: INFORMATION FOR THE USER. VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution. Cyanocobalamin

P AC K AG E L E AF L E T: INFORMAT I ON FO R THE USER. 500 mg, film-coated tablet Active substance: metformin hydrochloride

Package leaflet : information for the user. Dilute Adrenaline/Epinephrine Injection 1:10,000 adrenaline (epinephrine) (as acid tartrate) 0.

PACKAGE LEAFLET: INFORMATION FOR THE USER. ADRENALINE (TARTRATE) STEROP 1 mg/1 ml Solution for injection. Adrenaline (Levorenine, Epinephrine)

Package leaflet: Information for the patient. Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN

Perfalgan 10 mg/ml, solution for infusion

Package leaflet: Information for the user. Ondemet 4mg and 8mg Tablets (Ondansetron)

Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you.

Package leaflet: Information for the patient. Laxido Orange, powder for oral solution

PACKAGE LEAFLET: INFORMATION FOR THE USER. ADRENALINE (HCl) STEROP 0,8mg/1ml. Solution for injection. Adrenaline (Levorenine, Epinephrine)

PACKAGE LEAFLET

MRP-No. DE/H/0279/001/P/002 Dr. Scheffler Vitamin C, 1000mg, effervescent tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride

There is a risk of renal impairment in dehydrated children and adolescents.

PACKAGE LEAFLET: INFORMATION FOR THE USER. /.../ 2.5 mg orodispersible tablets. Desloratadine

1 What Anapen is and what it is used for?

1. What Xylocaine with adrenaline is and what it is used for

Package Leaflet: Information for the user

(NON-PRESCRIPTION) LEAFLET: USER INFORMATION. CALTRATE VITAMIN D3 600mg/400 IU, film-coated tablet Calcium and Cholecalciferol

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracetamol 500 mg Effervescent Tablets Paracetamol

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets

Testosterone propionate, phenylpropionate, isocaproate and decanoate. Please read this leaflet carefully before you start using SUSTANON 250.

Summary of the risk management plan (RMP) for Xultophy (insulin degludec / liraglutide)

SYNACTHEN i.m./i.v. tetracosactide hexaacetate

PACKAGE LEAFLET: INFORMATION FOR THE USER. METFORMINE MYLAN 850 mg dispersible tablets metformin hydrochloride

2 What you need to know before you have Ampiclox

I B2.4. Design of the patient information leaflet for VariQuin

New Zealand Consumer Medicine Information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Alvesco 40, 80 and 160 mcg Inhaler Ciclesonide

Package leaflet: Information for the patient. Bricanyl Tablets 5 mg terbutaline sulfate

Package leaflet: Information for the patient

Medication Guide Plavix (PLAV-iks) (clopidogrel bisulfate) tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin 500 mg film-coated tablets Metformin 850 mg film-coated tablets. Metformin hydrochloride

MEDICATION GUIDE. These serious side effects are described below:

Package leaflet: Information for the user. < ASPROFLASH and associated names > 500 mg coated tablet Acetylsalicylic acid

Vibramycin Capsules Doxycycline hyclate capsules USP. Vibra-Tabs Film Coated Tablets Doxycycline hyclate tablets USP

1g cream or ointment contains 1 mg methylprednisolone aceponate.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

N HUMAN Novo Nordisk Patient Information for Novolin N

[For POM]: Read all of this leaflet carefully before you start using this medicine.

Epipen Junior 150 micrograms solution for injection in pre-filled pen

UBISTESIN 1:200,000 and UBISTESIN FORTE 1:100,000

PATIENT INFORMATION LEAFLET. Forceval Capsules

Paracetamol apollo Paracetamol apollo Paracetamol

Package Leaflet: Information for the user. <Levetiracetam 750 mg, film-coated tablets> <Levetiracetam 1000 mg, film-coated tablets> Levetiracetam

DULCOLAX Tablets and Suppositories Bisacodyl

PATIENT INFORMATION LEAFLET. Forceval Junior Capsules

JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets

Intestinal Permeability Leaky Gut Syndrome Protocol Dr. Kurt Woeller, D.O.

Tradol SR 100mg Prolonged Release Tablets Tramadol hydrochloride

Early Access to Medicines Scheme Treatment protocol Information for patients

Teriflunomide (Aubagio) 14mg once daily tablet

Vincristine by short infusion Doxorubicin by injection Cyclophosphamide by injection Rituximab by an infusion over between 60 minutes to a few hours

Human Normal Immunoglobulin Solution for Intravenous Infusion.

Prochlorperazine 3 mg Buccal Tablets (PROCHLORPERAZINE MALEATE)

MEDICATION GUIDE SUBOXONE (Sub-OX-own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider:

1. What Malarone is and what it is used for

Read all of this leaflet carefully before you start taking this medicine

Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules

New Zealand Consumer Medicine Information

Galvumet Vildagliptin/Metformin hydrochloride Consumer Medicine Information

Package leaflet: Information for the user Humalog 200 units/ml, solution for injection in pre-filled pen insulin lispro

PATIENT MEDICATION INFORMATION

Package leaflet: Information for the patient. Entyvio 300 mg powder for concentrate for solution for infusion vedolizumab

HUMULIN R REGULAR INSULIN HUMAN INJECTION, USP (rdna ORIGIN) 100 UNITS PER ML (U-100)

Amlodipine 5 and 10 mg tablets

Shared Care Agreement Insulin Degludec (Tresiba )

SYNACTHEN DEPOT i.m. (tetracosactide hexaacetate) 1 mg/ml Suspension for injection

NEW ZEALAND CONSUMER MEDICINE INFORMATION Arrow - Diazepam

Share the important information in this Medication Guide with members of your household.

A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT

Package leaflet: Information for the patient. Co-amoxiclav 500 mg/125 mg Film-coated Tablets 500 mg/125 mg film-coated tablets

Dalacin C 150 mg Hard Capsules Clindamycin (as clindamycin hydrochloride)

Medication Guide. SYMLIN (SĬM-lĭn) (pramlintide acetate) injection

PATIENT INFORMATION LEAFLET. Calcium Sandoz Syrup calcium glubionate and calcium lactobionate

Humulin (HU-mu-lin) R

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR ATRIAL FIBRILLATION

PATIENT INFORMATION LEAFLET

How To Take Xarelto

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

Motilium 1mg/ml Oral Suspension Domperidone

New Zealand Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist.

IMPORTANT: PLEASE READ

Allopurinol Allopurinol

CVP Chemotherapy Regimen for Lymphoma Information for Patients

PACKAGE LEAFLET: INFORMATION FOR THE USER Omeprazol XXX 40 mg powder for solution for infusion omeprazole

Sativex Cannabis sativa L. extracts (delta-9-tetrahydrocannabinol and cannabidiol) Oromucosal Spray 5.5 / 10 ml

MEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa)

Warfarin therapy for stroke patients with atrial fibrillation

IMPORTANT: PLEASE READ

ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE)

A ragweed pollen as a treatment for a ragweed allergy? It s called immunotherapy.

Package leaflet: Information for the patient. Desloratadine Actavis 5 mg orodispersible tablets desloratadine

MEDICATION GUIDE SYLATRON (SY-LA-TRON) (Peginterferon alfa-2b)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Methotrexate 2.5 mg Tablets

A list of all medications you are taking also include any vitamins, supplements, over-the-counter medicines, or herbal products

Transcription:

Package Leaflet: Information for the User Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid For use in adults Active substance: Alpha-lipoic acid, Trometamol salt (1:1) Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However, you still need to use Thioctacid 600 T carefully to get the best results from it. Keep this leaflet. You may need to read it again. If you have further questions, please ask your doctor or your pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. This medicine has been prescribed for you personally and you should not pass it on to others. It may harm them, even if their symptoms are the same as yours. In this leaflet: 1. What Thioctacid 600 T is and what it is used for 2. Before you use Thioctacid 600 T 3. How to use Thioctacid 600 T 4. Possible side effects 5. How to store Thioctacid 600 T 6. Further information 1. WHAT THIOCTACID 600 T IS AND WHAT IT IS USED FOR Αlpha-lipoic acid, the active substance in Thioctacid 600 T, is a substance which is formed in the body's metabolism and it has an influence on certain metabolic functions of the body. Moreover, alpha-lipoic acid has anti-oxidative properties which protect the nerve cell against reactive decomposition products. Uses: Thioctacid 600 T is used for treatment of symptoms of peripheral (sensomotor) diabetic polyneuropathy. 2. BEFORE YOU USE THIOCTACID 600 T 1

Do not use Thioctacid 600 T - if you are allergic (hypersensitive) to alpha-lipoic acid or any of the other ingredients of Thioctacid 600 T. Take special care with Thioctacid 600 T: In relation with the use of Thioctacid 600 T as solution for injection and/or infusion, allergic reactions (hypersensitivity reactions) up to life-threatening shock (acute collapse of the circulation) were seen (refer to section "Side Effects"). Therefore, your treating physician will monitor you for the occurrence of early symptoms (such as itching, nausea, sickness etc.) while you are treated with Thioctacid 600 T. Should these symptoms occur, treatment must be stopped immediately and further therapeutic measures must be taken, if appropriate. After use of Thioctacid 600 T, the urine may smell differently, however, this is not of clinical relevance. Children: Children and adolescents must not be treated with Thioctacid 600 T as there is insufficient experience with this age group. Using Thioctacid 600 T with other medicines: Please tell your doctor or pharmacist if you are taking/using or have recently taken/used any other medicines, including medicines obtained without prescription. Please be aware that the following applies also for medicines used recently. It cannot be ruled out that concomitant use of Thioctacid 600 T may neutralize the effect of Cisplatin (an anti-cancer agent). The blood-sugar reducing effect of anti-diabetic agents (insulin and/or other anti-diabetic agents) may be enhanced. Therefore - in particular when starting treatment with Thioctacid 600 T fine-meshed monitoring of the blood-sugar values will be required. In order to avoid symptoms of hypoglycaemia, it may become necessary in individual cases to reduce the dose of insulin and/or of the oral anti-diabetic agent according to the instructions given by the treating physician. Taking Thioctacid 600 T with food and drink Regular consumption of alcohol is an important risk factor for the development and the progression of neuropathic clinical pictures and may therefore also have a negative influence on the success of treatment with Thioctacid 600 T. For this reason, it is generally recommended for patients suffering from diabetic neuropathy (polyneuropathy) to avoid the consumption of alcohol as far as possible. This shall also apply to treatment-free intervals. Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. 2

It is one of the general principles of drug therapy that any medicinal product shall be used during pregnancy and/or the breast-feeding period only after the risk-benefit ratio has been weighed carefully. Therefore, it is recommended that pregnant and/or breast-feeding women shall undergo treatment with alpha-lipoic acid only after careful recommendation and monitoring by their doctor as there is no experience with these patient collectives so far. Special animal studies have not shown any indication of fertility disorders or harmful effects on foetal development. There are no reports about a possible passage of alpha-lipoic acid into the breast milk. Driving and using machines No special precautionary measures need to be taken. 3. HOW TO USE THIOCTACID 600 T Always use Thioctacid 600 T exactly as specified in this package leaflet. You should check with your doctor or pharmacist if you are not sure. Unless otherwise prescribed by your doctor, the usual dose is: In cases of symptoms of peripheral (sensomotor) diabetic polyneuropathy, the daily dosage is one ampoule of Thioctacid 600 T (equivalent to 600 mg of alpha-lipoic acid). Method of administration: Thioctacid 600 T can be given either by intravenous injection of the undiluted solution or mixed with physiological salt solution in form of an intravenous drip (short-duration infusion). In these cases, Thioctacid 600 T must be administered over a period of not less than 12 minutes. Due to the fact that the active substance is sensitive to light, the short-duration infusion shall be prepared just shortly before its use. The infusion solution must be protected from light (e. g. by means of aluminium foil). When protected from light, the infusion solution has a shelf life of about 6 hours. Duration of treatment: During the initial phase of treatment, the injection solution will be used for a period of 2 to 4 weeks. It is recommended to continue treatment by taking 600 mg of alpha-lipoic acid in form of tablets for oral use. Should you have the impression that the effect of Thioctacid 600 T is either too strong or too weak, discuss this with your doctor or your pharmacist. If you take more Thioctacid 600 T than you should In case of overdosing, nausea, vomiting and headache may occur. In isolated cases, severe partially life-threatening - intoxication symptoms (including generalized seizure, imbalance of the acid-base equilibrium accompanied by acidosis of the blood and/or severe disorders of blood clotting) were seen after uptake of more than 10 g of alpha-lipoic acid, in particular in connection with high consumption of alcohol. For this reason, suspected significant overdosing with Thioctacid 600 T shall require immediate admission to a hospital and initiation of standard measures used to treat 3

intoxication. Treatment of any occurring symptoms of intoxication shall be based on the principles of modern intensive care and shall be carried out symptomatically. If you forget to use Thioctacid 600 T Do not take a double dose to make up for a forgotten dose. If you stop using Thioctacid 600 T Do not stop treatment with Thioctacid 600 T without first consulting your doctor. Otherwise, your symptoms may aggravate. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, Thioctacid 600 T can cause side effects, although not everybody gets them. Evaluation of the side effects is based on the following frequency information: Very common: Common: Uncommon: Rare: more than 1 of 10 treated patients less than 1 of 10, however more than 1 of 100 treated patients less than 1 of 100, however more than 1 of 1,000 treated patients less than 1 of 1,000, however more than 1 of 10,000 treated patients less than 1 of 10,000 treated patients, including isolated reports Possible side effects: Gastro-intestinal tract Uncommon: Nausea and vomiting Application site reactions Reactions at the application site Hypersensitivity reactions Allergic reactions such as skin rash, nettle rash (urticaria) and itching as well as allergic reactions of the whole body up to shock may occur. Nervous system: Uncommon: Change or disturbance of taste sensation Cramps as well as double vision Blood and blood vessels Very rare Skin bleeding (purpura), disorders of the blood platelets and consequently of blood clotting (thrombopathy) General disorders Common: 4

After rapid intravenous injection, pressure in the head and difficulty in breathing may appear which will remit spontaneously. Due to enhanced glucose utilization, the blood-sugar level may drop. In this relation, hypoglycaemic symptoms accompanied by dizziness, sweating, headache and blurred vision were described. Countermeasures: If you experience any symptoms of the side effects mentioned above, do not use Thioctacid 600 T again. Please inform your doctor. He/she will then make a decision on the severity as well as on any further measures, if appropriate. Upon the first symptoms of an allergic reaction, stop taking this medicine and contact a doctor immediately. If you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 5. HOW TO STORE THIOCTACID 600 T Keep out of the reach and sight of children. Do not use Thioctacid 600 T after the expiry date which is stated on the carton and the container after "Use before". Storage conditions Store the container in the carton to protect the content from light. Information concerning in-use shelf life - Protect an infusion solution prepared with Thioctacid 600 T from light (e. g. by means of aluminium foil). - When protected from light, the infusion solution prepared with physiologic salt solution has a shelf life of 6 hours. 6. FURTHER INFORMATION What Thioctacid 600 T contains: The active substance is: 24 ml of Solution for Injection contain 952.3 mg of alpha-lipoic acid, Trometamol salt (equivalent to 600 mg of alpha-lipoic acid) The other ingredients are: Trometamol, Water for injection How Thioctacid 600 T looks like and contents of the pack: Container: 25-ml amber glass ampoules, hydrolytic class I, with colour ring coding; packed in PS blisters containing 5 ampoules each, sealed with PS film, white, 500 µm 5

Pack sizes: Original pack of 5 ampoules (N1) containing 24 ml of solution for injection each. Original pack of 10 ampoules (N2) containing 24 ml of solution for injection each. Original pack of 20 ampoules (N3) containing 24 ml of solution for injection each. Marketing Authorization Holder MEDA Pharma GmbH & Co. KG Benzstrasse 1 61352 Bad Homburg (Germany) Phone: + 49 (06172) 888-01 Fax: + 49 (06172) 888-2740 E-mail: medinfo@medapharma.de This leaflet was last approved in 08/2007. Prescription drug only 6